0

BONIVA از شرکت ROCHE

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

BONIVA از شرکت ROCHE

New Drug Application (NDA): 021858

Company: ROCHE

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
BONIVA IBANDRONATE SODIUM EQ 3MG BASE/3ML INJECTABLE;INTRAVENOUS Discontinued

None

Yes No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
01/06/2006 ORIG-1 Approval

Type 3 – New Dosage Form

STANDARD

Label (PDF)

Letter (PDF)

Review

https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021858s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021858s000ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021858s000TOC.cfm

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
12/07/2016 SUPPL-22 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021858s022lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021858Orig1s022ltr.pdf

07/22/2015 SUPPL-21 Manufacturing (CMC)

Label is not available on this site.

04/08/2015 SUPPL-20 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021858s020lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021858Orig1s020ltr.pdf

03/18/2015 SUPPL-19 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021858s019lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021858Orig1s019ltr.pdf

05/04/2015 SUPPL-18 Manufacturing (CMC)

Label is not available on this site.

09/08/2014 SUPPL-17 Manufacturing (CMC)

Label is not available on this site.

10/20/2014 SUPPL-16 Manufacturing (CMC)

Label is not available on this site.

06/18/2014 SUPPL-15 Manufacturing (CMC)

Label is not available on this site.

04/19/2013 SUPPL-14 Labeling-Medication Guide

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021858s008s013s014lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021858Orig1s008,s013,s014ltr.pdf

04/19/2013 SUPPL-13 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021858s008s013s014lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021858Orig1s008,s013,s014ltr.pdf

07/01/2011 SUPPL-12 REMS-Modified

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021858s012ltr.pdf

08/10/2011 SUPPL-10 Labeling-Package Insert

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021858s010ltr.pdf

01/25/2011 SUPPL-9 REMS-Proposal

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021858s009lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021858s009ltr.pdf

04/19/2013 SUPPL-8 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021858s008s013s014lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021858Orig1s008,s013,s014ltr.pdf

02/12/2007 SUPPL-4 Labeling

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021858s004ltr.pdf

08/07/2006 SUPPL-1 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021858s001lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021858s001LTR.pdf

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
12/07/2016 SUPPL-22

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021858s022lbl.pdf
04/08/2015 SUPPL-20

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021858s020lbl.pdf
03/18/2015 SUPPL-19

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021858s019lbl.pdf
04/19/2013 SUPPL-14

Labeling-Medication Guide

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021858s008s013s014lbl.pdf
04/19/2013 SUPPL-13

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021858s008s013s014lbl.pdf
04/19/2013 SUPPL-8

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021858s008s013s014lbl.pdf
01/25/2011 SUPPL-9

REMS-Proposal

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021858s009lbl.pdf
08/07/2006 SUPPL-1

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021858s001lbl.pdf
01/06/2006 ORIG-1 Approval

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021858s000lbl.pdf
حتما بخوانید : BLOXIVERZ از شرکت EXELA PHARMA
برچسب‌ها:

نظرات کاربران